UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Methods for Implementing and Reporting Patient-Reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials

Clinical therapeutics, 2016-04, Vol.38 (4), p.821-830

2016

Volltextzugriff (PDF)

The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review

Supportive care in cancer, 2016-08, Vol.24 (8), p.3669-3676

2016

Volltextzugriff (PDF)

Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Clinical trials (London, England), 2021-02, Vol.18 (1), p.104-114

2021

Volltextzugriff (PDF)

Feasibility of Long-Term Patient Self-Reporting of Toxicities From Home via the Internet During Routine Chemotherapy

Journal of clinical oncology, 2013-07, Vol.31 (20), p.2580-2585

2013

Volltextzugriff (PDF)

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial

International journal of radiation oncology, biology, physics, 2017-06, Vol.98 (2), p.409-418

2017

Volltextzugriff (PDF)

Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Health and quality of life outcomes, 2016-02, Vol.14 (24), p.24, Article 24

2016

Volltextzugriff (PDF)

Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2

Quality of life research, 2022-04, Vol.31 (4), p.1069-1080

2022

Volltextzugriff (PDF)

Correction to: Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2

Quality of life research, 2022-04, Vol.31 (4), p.1081-1081

2022

Volltextzugriff (PDF)

Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial

JAMA oncology, 2020-02, Vol.6 (2), p.e193332

2020

Volltextzugriff (PDF)

Evaluation of different recall periods for the US National Cancer Institute’s PRO-CTCAE

Clinical trials (London, England), 2017-06, Vol.14 (3), p.255-263

2017

Volltextzugriff (PDF)

Quality of life in long-term survivors of advanced melanoma treated with checkpoint inhibitors

Journal for immunotherapy of cancer, 2020-03, Vol.8 (1), p.e000260

2020

Volltextzugriff (PDF)

Linguistic validation of the Spanish version of the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Supportive care in cancer, 2016-07, Vol.24 (7), p.2843-2851

2016

Volltextzugriff (PDF)

Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2022-06, Vol.327 (24), p.2413

2022

Volltextzugriff (PDF)

Substance Abuse in Cancer Pain

Current pain and headache reports, 2010-08, Vol.14 (4), p.268-275

2010

Volltextzugriff (PDF)

Harnessing Technology to Improve Clinical Trials: Study of Real-Time Informatics to Collect Data, Toxicities, Image Response Assessments, and Patient-Reported Outcomes in a Phase II Clinical Trial

Journal of clinical oncology, 2013-06, Vol.31 (16), p.2004-2009

2013

Volltextzugriff (PDF)

Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39)

Journal of clinical oncology, 2023-10, Vol.41 (29), p.4652

2023

Volltextzugriff (PDF)

Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Journal of the American Medical Informatics Association : JAMIA, 2019-04, Vol.26 (4), p.276-285

2019

Volltextzugriff (PDF)

Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39)

Quality of life research, 2024-07, Vol.33 (7), p.1985-1995

2024

Volltextzugriff (PDF)

Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048

Journal of clinical oncology, 2018-11, Vol.36 (31), p.JCO2018788620-3125

2018

Volltextzugriff (PDF)

An Exploratory Analysis of the “Was It Worth It?” Questionnaire as a Novel Metric to Capture Patient Perceptions of Cancer Treatment

Value in health, 2022-07, Vol.25 (7), p.1081-1086

2022

Volltextzugriff (PDF)

Application of a Bayesian graded response model to characterize areas of disagreement between clinician and patient grading of symptomatic adverse events

Journal of patient-reported outcomes, 2018-12, Vol.2 (1), p.56-12, Article 56

2018

Volltextzugriff (PDF)

The experience of financial toxicity among advanced melanoma patients treated with immunotherapy

Journal of psychosocial oncology, 2021, Vol.39 (2), p.285-293

2021

Volltextzugriff (PDF)

Evaluating Treatment Tolerability Using the Toxicity Index With Patient-Reported Outcomes Data

Journal of pain and symptom management, 2022-02, Vol.63 (2), p.311-320

2022

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(47)

Publikationsform

Sprache

Englisch
(53)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Humans
(26)
Oncology
(18)
Male
(16)
Female
(15)
Middle Aged
(15)
Patient Reported Outcome Measures
(15)
Adult
(14)
Aged
(14)
Self Report
(12)
Clinical Trials
(11)
Patients
(11)
Health Care Sciences & Services
(10)
Quality Of Life
(10)
United States
(10)
Antineoplastic Agents - Adverse Effects
(9)
Cancer
(9)
Medicine
(9)
National Cancer Institute
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Methods for Implementing and Reporting Patient-Reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials

The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review

Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Feasibility of Long-Term Patient Self-Reporting of Toxicities From Home via the Internet During Routine Chemotherapy

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial

Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2

Correction to: Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2

Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

Evaluation of different recall periods for the US National Cancer Institute’s PRO-CTCAE

Quality of life in long-term survivors of advanced melanoma treated with checkpoint inhibitors

Linguistic validation of the Spanish version of the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial

Substance Abuse in Cancer Pain

Harnessing Technology to Improve Clinical Trials: Study of Real-Time Informatics to Collect Data, Toxicities, Image Response Assessments, and Patient-Reported Outcomes in a Phase II Clinical Trial

Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39)

Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39)

Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048

An Exploratory Analysis of the “Was It Worth It?” Questionnaire as a Novel Metric to Capture Patient Perceptions of Cancer Treatment

Application of a Bayesian graded response model to characterize areas of disagreement between clinician and patient grading of symptomatic adverse events

The experience of financial toxicity among advanced melanoma patients treated with immunotherapy

Evaluating Treatment Tolerability Using the Toxicity Index With Patient-Reported Outcomes Data

Suchergebnisse filtern